| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2020 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ROIVANT SCIENCES LTD | 9 | Q4 2023 | 99.0% |
| APPLIED MOLECULAR TRANS INC | 8 | Q3 2023 | 34.0% |
| SNAP INC | 5 | Q1 2024 | 39.3% |
| CYCLO THERAPEUTICS INC | 3 | Q2 2024 | 100.0% |
| OSCAR HEALTH INC | 2 | Q1 2022 | 79.6% |
| NOVA LTD | 1 | Q1 2024 | 2.8% |
View Founders Fund VI Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Founders Fund VI Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.